Autolus
Blood & Organ Banks · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
191 Wood Lane, London, Greater London, W...Phone Number
+44 2038296230Website
www.autolus.comRevenue
$117.4 MillionStock Symbol
AUTLIndustry
About Autolus
Autolus Therapeutics plc is a commercial-stage biopharmaceutical company headquartered in London, United Kingdom, founded in 2014. The company is focused on developing, manufacturing, and delivering next-generation programmed T cell therapies for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus engineers precisely targeted, controlled, and highly active T cell therapies designed to better recognize target cells, break down their defense mechanisms, and eliminate them.Explore more
Autolus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Autolus
Compare insights from companies similar to Autolus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Autolus Tech Stack
A closer look at the technologies used by Autolus
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Autolus
Sign Up For FreeTo access detailed company insights
Autolus Therapeutics plc is a commercial-stage biopharmaceutical company headquartered in London, United Kingdom, founded in 2014. The company is focused on developing, manufacturing, and delivering next-generation programmed T cell therapies for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell p... Read More
